• About
    • Mission, Vision and Values
    • Team
    • Board of Directors
    • Investors
  • Pipeline
  • VICOMER™ Platform
    • VICOMER™ Platform
    • Scientific Publications
    • Collaborators
  • News
  • Join Our Team
  • Contact Us
VICO Therapeutics
Biotech VICO Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases

Biotech VICO Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases

by VICO Therapeutics | Jul 29, 2020 | Press Release

AON-platform with focus on therapies nearing phase I trials for forms of Spinocerebellar Ataxia and Huntington Disease Other early discovery stage RNA editing platform focuses on RETT syndrome Funding led by LSP, co-led by Kurma Partners, supported by Pontifax, Droia...

© 2022 VICO Therapeutics | All rights reserved | Privacy statement


Designed and developed by Root Agency